Lanean...
Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines
Chronic infections with HBV and HCV continue to be major public health problems, with hundreds of millions of people infected worldwide; this is despite the availability of both an effective prophylactic HBV vaccine for more than 3 decades and potent direct antivirals for HBV and, more recently, HCV...
Gorde:
| Argitaratua izan da: | Pathog Immun |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Pathogens and Immunity
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486412/ https://ncbi.nlm.nih.gov/pubmed/28664194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20411/pai.v2i1.201 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|